EFFICACY AND SAFETY OF VALOCTOCOGENE ROXAPARVOVEC 4 YEARS AFTER GENE TRANSFER IN GENER8-1 MC Ozelo; AD Leavitt; J Mahlangu; G Kenet; SW Pipe; S Chou; R Klamroth; F Peyvandi; T Robinson; GT Group;

BLEEDING, FVIII ACTIVITY, AND SAFETY 3 YEARS AFTER GENE TRANSFER WITH VALOCTOCOGENE ROXAPARVOVEC: RESULTS FROM GENER8-1 MC Ozelo; J Mahlangu; B Madan; J Mason; F Peyvandi; AV Drygalski; G Yamaguti-Hayakawa; TM Robinson; SW Pipe; TT Gener-Eigh;

HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY AD Shapiro; A Abraham; S Linari; JS Neergaard; J Odgaard-Jensen; JJT Zaw; H Tran; GG Fabbron;